OBJECTIVES: To demonstrate the ability of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) to discriminate between cognitively-impaired individuals and those with adequate functioning in a sample of schizophrenic and bipolar patients, as well as in a control group. METHODS: The SCIP-S, together with a full neuropsychological battery, was administered to three groups: patients with schizophrenia, patients diagnosed with bipolar disorder I, and controls. The battery scores were used to perform a standardization with respect to the control group and this served to determine the comparison groups (cognitively impaired versus unimpaired) for each of the subtests of the SCIP-S. A full analysis of decision validity was conducted on the basis of receiver operating characteristic curves (sensitivity and specificity, +LR and -LR, PPV and NPV). RESULTS: All the subtests yielded adequate values for sensitivity and specificity with the proposed cut-off points, while the total score of the SCIP (<70) was associated with a sensitivity of 87.9 and specificity of 80.6. CONCLUSIONS: The SCIP-S shows adequate decision validity as a screening tool for cognitive deficit in patients diagnosed with schizophrenia or bipolar disorder. 2009 Elsevier B.V. All rights reserved.
OBJECTIVES: To demonstrate the ability of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) to discriminate between cognitively-impaired individuals and those with adequate functioning in a sample of schizophrenic and bipolarpatients, as well as in a control group. METHODS: The SCIP-S, together with a full neuropsychological battery, was administered to three groups: patients with schizophrenia, patients diagnosed with bipolar disorder I, and controls. The battery scores were used to perform a standardization with respect to the control group and this served to determine the comparison groups (cognitively impaired versus unimpaired) for each of the subtests of the SCIP-S. A full analysis of decision validity was conducted on the basis of receiver operating characteristic curves (sensitivity and specificity, +LR and -LR, PPV and NPV). RESULTS: All the subtests yielded adequate values for sensitivity and specificity with the proposed cut-off points, while the total score of the SCIP (<70) was associated with a sensitivity of 87.9 and specificity of 80.6. CONCLUSIONS: The SCIP-S shows adequate decision validity as a screening tool for cognitive deficit in patients diagnosed with schizophrenia or bipolar disorder. 2009 Elsevier B.V. All rights reserved.
Authors: Ana M Sánchez-Torres; María Rosa Elosúa; Ruth Lorente-Omeñaca; Lucía Moreno-Izco; Victor Peralta; Joseph Ventura; Manuel J Cuesta Journal: Eur Arch Psychiatry Clin Neurosci Date: 2016-06-06 Impact factor: 5.270
Authors: G Lahera; L Boada; E Pousa; I Mirapeix; G Morón-Nozaleda; L Marinas; L Gisbert; M Pamiàs; M Parellada Journal: J Autism Dev Disord Date: 2014-08
Authors: Kathryn E Lewandowski; Julie M McCarthy; Dost Öngür; Lesley A Norris; Geoffrey Z Liu; Richard J Juelich; Justin T Baker Journal: Schizophr Res Date: 2018-08-17 Impact factor: 4.939